The proposed study will investigate regulation of the insulin receptor (IR) by insulin and glucocorticoids. When in excess both hormones can cause insulin resistance and diabetes. The first series of studies will focus on the in vitro regulation of the IR by glucocorticoids. We have recently reported that, in IM-9 cultured lymphocytes, glucocorticoids increase IR mRNA levels and IR gene transcription. In addition, we have sequenced the promoter region of the IR gene, and have identified a potential glucocorticoid response element (GRE) consensus sequence in the first intron. DNA binding, DNAase I sensitivity and transient (and/or stable) transfection studies will be carried out to determine whether this sequence functions as a GRE to convey glucocorticoid regulation upon the IR. Further genomic sequences will be obtained to identify additional regulatory elements. The second series of studies will focus on the in vitro regulation of the IR by insulin. In several cell types we have recently observed that insulin decreases IR biosynthesis and mRNA levels. We plan to determine whether this effect occurs either at the level of RNA transcription or at the level of mRNA stability. If the effect occurs at the level of transcription, then the regulatory elements in the IR gene will be investigated. Parallel to these two in vitro studies, in vivo studies will be carried out in adrenalectomized, sham operated and corticosterone-treated normal and diabetic rats. Since in vivo studies indicate that glucocorticoids down-regulate the IR whereas most in vitro studies indicate that glucocorticoids up-regulate the IR, we will attempt to explain the variables occurring in vivo. One hypothesis is that the hyperinsulinemia induced by glucocorticoids in vivo down- regulates the IR and overrides the up-regulation induced by glucocorticoids. These in vitro and in vivo studies should provide important information, therefore, concerning the mechanisms through which two major hormones regulate the IR.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK026667-10
Application #
3227983
Study Section
Metabolism Study Section (MET)
Project Start
1979-03-01
Project End
1991-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
10
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Mount Zion Hospital and Medical Center
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94120
Blouet, Clémence; Schwartz, Gary J (2012) Duodenal lipid sensing activates vagal afferents to regulate non-shivering brown fat thermogenesis in rats. PLoS One 7:e51898
Blouet, Clemence; Liu, Shun-Mei; Jo, Young-Hwan et al. (2012) TXNIP in Agrp neurons regulates adiposity, energy expenditure, and central leptin sensitivity. J Neurosci 32:9870-7
Brunetti, A; Brunetti, L; Foti, D et al. (1996) Human diabetes associated with defects in nuclear regulatory proteins for the insulin receptor gene. J Clin Invest 97:258-62
Hartmann, K K; Baier, T G; Papa, V et al. (1992) A monoclonal antibody to the T-cell receptor increases IGF-I receptor content in normal T-lymphocytes: comparison with phytohemagglutinin. J Cell Biochem 48:81-5
Mamula, P W; Goldfine, I D (1992) Cloning and characterization of the human insulin-like growth factor-I receptor gene 5'-flanking region. DNA Cell Biol 11:43-50
Rosenthal, S M; Brunetti, A; Brown, E J et al. (1991) Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II. J Clin Invest 87:1212-9
Rosenthal, S M; Brown, E J; Brunetti, A et al. (1991) Fibroblast growth factor inhibits insulin-like growth factor-II (IGF-II) gene expression and increases IGF-I receptor abundance in BC3H-1 muscle cells. Mol Endocrinol 5:678-84
Mamula, P W; McDonald, A R; Brunetti, A et al. (1990) Regulating insulin-receptor-gene expression by differentiation and hormones. Diabetes Care 13:288-301
Okabayashi, Y; Maddux, B A; McDonald, A R et al. (1989) Mechanisms of insulin-induced insulin-receptor downregulation. Decrease of receptor biosynthesis and mRNA levels. Diabetes 38:182-7
Hawley, D M; Maddux, B A; Patel, R G et al. (1989) Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase. J Biol Chem 264:2438-44

Showing the most recent 10 out of 19 publications